Nadine Cohen

Nadine Cohen

UNVERIFIED PROFILE

Are you Nadine Cohen?   Register this Author

Register author
Nadine Cohen

Nadine Cohen

Publications by authors named "Nadine Cohen"

Are you Nadine Cohen?   Register this Author

22Publications

592Reads

39Profile Views

Genome-wide association study of paliperidone efficacy.

Pharmacogenet Genomics 2017 01;27(1):7-18

aNeuroscience, Janssen Research & Development, LLC bJanssen Scientific Affairs, LLC, Titusville cJanssen Research & Development, LLC, Raritan dBlue Note Biosciences, LLC, Princeton, New Jersey eBiostatistics and Bioinformatics, The Scripps Translational Science Institute fDepartment of Molecular and Experimental Medicine, The Scripps Research Institute gScripps Health hHuman Biology, J. Craig Venter Institute, La Jolla iMD Revolution, San Diego, California, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/FPC.0000000000000250DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5152628PMC
January 2017

SULT4A1 haplotype: conflicting results on its role as a biomarker of antipsychotic response.

Pharmacogenomics 2014 ;15(12):1557-64

Neuroscience Therapeutic Area, Janssen Research & Development, LLC, 1125 Trenton Harbourton Rd, Titusville, NJ, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/pgs.14.105DOI Listing
June 2015

Large-scale candidate gene study to identify genetic risk factors predictive of paliperidone treatment response in patients with schizophrenia.

Pharmacogenet Genomics 2015 Apr;25(4):173-85

aJanssen Research & Development, LLC, Raritan bJanssen Scientific Affairs, LLC, Titusville, New Jersey cJanssen Research & Development, LLC, Titusville, New Jersey, USA.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/FPC.0000000000000122DOI Listing
April 2015

GWAS meta analysis identifies TSNARE1 as a novel Schizophrenia / Bipolar susceptibility locus.

Sci Rep 2013 Oct 29;3:3075. Epub 2013 Oct 29.

1] The Center for Applied Genomics, The Children's Hospital of Philadelphia, Philadelphia, PA, 19104, USA [2] Department of Pediatrics, University of Pennsylvania School of Medicine, Philadelphia, PA, 19104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep03075DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3810676PMC
October 2013

Returning genetic research results to individuals: points-to-consider.

Bioethics 2006 Feb;20(1):24-36

Genetics Research, GlaxoSmithKline, 5 Moore Drive, RTP NC 27709, USA.

View Article

Download full-text PDF

Source
February 2006

Genetic variations of KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 in drug-induced long QT syndrome patients.

J Mol Med (Berl) 2004 Mar 4;82(3):182-8. Epub 2004 Feb 4.

Department of Pharmacogenomics, Johnson & Johnson Pharmaceutical Research and Development, Turnhoutseweg 30, Beerse, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00109-003-0522-zDOI Listing
March 2004

Mutation analysis in congenital Long QT Syndrome--a case with missense mutations in KCNQ1 and SCN5A.

Genet Test 2003 ;7(1):57-61

Department of Pharmacogenomics, Johnson & Johnson Pharmaceutical Research and Development, Beerse, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/109065703321560958DOI Listing
November 2003

A novel mutation in the chloride channel gene, CLCNKB, as a cause of Gitelman and Bartter syndromes.

Kidney Int 2003 Jan;63(1):24-32

Department of Nephrology, Rambam Medical Center, Faculty of Medicine, Technion - Israel Institute of Technology, Haifa, Israel.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S008525381548841
Publisher Site
http://dx.doi.org/10.1046/j.1523-1755.2003.00730.xDOI Listing
January 2003

A novel mutation (T65P) in the PAS domain of the human potassium channel HERG results in the long QT syndrome by trafficking deficiency.

J Biol Chem 2002 Dec 26;277(50):48610-6. Epub 2002 Sep 26.

Department of Pharmacogenomics, Johnson & Johnson Pharmaceutical Research and Development, Beerse B-2340, Belgium.

View Article

Download full-text PDF

Source
http://www.jbc.org/lookup/doi/10.1074/jbc.M206569200
Publisher Site
http://dx.doi.org/10.1074/jbc.M206569200DOI Listing
December 2002

Data mining of public SNP databases for the selection of intragenic SNPs.

Hum Mutat 2002 Sep;20(3):162-73

Department Pharmacogenomics, Janssen Research Foundation, Beerse, Belgium.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/humu.10107
Publisher Site
http://dx.doi.org/10.1002/humu.10107DOI Listing
September 2002

A novel mutation in the deoxyguanosine kinase gene causing depletion of mitochondrial DNA.

Ann Neurol 2002 Aug;52(2):237-9

University Department of Clinical Neurosciences, Royal Free and University College Medical School, University College London, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ana.10247DOI Listing
August 2002

Lack of plasma membrane targeting of a G172D mutant thiamine transporter derived from Rogers syndrome family.

Mol Med 2002 Aug;8(8):462-74

Department of Molecular Genetics, the Rappaport Institute for Research in the Medical Sciences and the B. Rappaport Faculty of Medicine, The Technion-Israel Institute of Technology, Haifa, Israel.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2040007PMC
August 2002